FastCompChem is a Portuguese startup revolutionizing drug discovery and molecular modeling by leveraging advanced quantum mechanics and AI. Its slogan "Combining quantum chemistry and AI for drug development and molecular modelling" encapsulates its core focus. The company addresses the limitations of current technologies in drug discovery, particularly in ensuring safety to combat attrition. FastCompChem is committed to developing tools and algorithms that prioritize safety, utilizing novel approaches for cheminformatics to overcome the lack of experimental data points and cover extensive chemical space. The startup's applications extend to early toxicity assessment in drug discovery, aligning with the 3Rs goals through in-vitro approaches. Established in 2019, FastCompChem operates within the AI, Biotechnology, and Machine Learning sectors. Its recent €100.00KSeed Round investment on 30 December 2020, secured from Portugal Ventures, underscores investor confidence in its groundbreaking approach.
No recent news or press coverage available for FastCompChem.